Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency.
about
Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical FeaturesMetabolic autopsy with next generation sequencing in sudden unexpected death in infancy: Postmortem diagnosis of fatty acid oxidation disordersTreatment of muscle weakness in neuromuscular disorders.
P2860
Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clinically symptomatic heteroz ...... ferase II (CPT II) deficiency.
@ast
Clinically symptomatic heteroz ...... ferase II (CPT II) deficiency.
@en
type
label
Clinically symptomatic heteroz ...... ferase II (CPT II) deficiency.
@ast
Clinically symptomatic heteroz ...... ferase II (CPT II) deficiency.
@en
prefLabel
Clinically symptomatic heteroz ...... ferase II (CPT II) deficiency.
@ast
Clinically symptomatic heteroz ...... ferase II (CPT II) deficiency.
@en
P2093
P2860
P1476
Clinically symptomatic heteroz ...... ferase II (CPT II) deficiency.
@en
P2093
Marcus Deschauer
Pushpa Raj Joshi
Stephan Zierz
P2860
P2888
P304
P356
10.1007/S00508-012-0296-9
P577
2012-11-27T00:00:00Z
P6179
1012964602